N4 Pharma (N4P) Competitors GBX 0.47 -0.01 (-1.26%) As of 03/28/2025 11:19 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock N4P vs. HELD, HLN, BXP, HIK, HCM, INDV, AMYT, APH, AGY, and ANCRShould you be buying N4 Pharma stock or one of its competitors? The main competitors of N4 Pharma include Hellenic Dynamics (HELD), Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Alliance Pharma (APH), Allergy Therapeutics (AGY), and Animalcare Group (ANCR). These companies are all part of the "drug manufacturers - specialty & generic" industry. N4 Pharma vs. Hellenic Dynamics Haleon Beximco Pharmaceuticals Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Alliance Pharma Allergy Therapeutics Animalcare Group N4 Pharma (LON:N4P) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment and dividends. Does the media prefer N4P or HELD? In the previous week, N4 Pharma's average media sentiment score of 0.00 equaled Hellenic Dynamics'average media sentiment score. Company Overall Sentiment N4 Pharma Neutral Hellenic Dynamics Neutral Does the MarketBeat Community believe in N4P or HELD? N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users. CompanyUnderperformOutperformN4 PharmaOutperform Votes10365.61% Underperform Votes5434.39% Hellenic DynamicsN/AN/A Is N4P or HELD more profitable? Hellenic Dynamics has a net margin of 0.00% compared to N4 Pharma's net margin of -18,399.86%. N4 Pharma's return on equity of -90.68% beat Hellenic Dynamics' return on equity.Company Net Margins Return on Equity Return on Assets N4 Pharma-18,399.86% -90.68% -56.00% Hellenic Dynamics N/A -364.21%N/A Which has preferable earnings and valuation, N4P or HELD? N4 Pharma has higher revenue and earnings than Hellenic Dynamics. N4 Pharma is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioN4 Pharma£8.84K228.45-£1.63M-£0.35-1.35Hellenic DynamicsN/AN/A-£5.22M-£3.55-0.27 Do insiders & institutionals hold more shares of N4P or HELD? 0.1% of Hellenic Dynamics shares are held by institutional investors. 18.0% of N4 Pharma shares are held by company insiders. Comparatively, 72.9% of Hellenic Dynamics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryN4 Pharma and Hellenic Dynamics tied by winning 5 of the 10 factors compared between the two stocks. Remove Ads Get N4 Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart N4P vs. The Competition Export to ExcelMetricN4 PharmaDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£2.02M£2.27B£5.63B£2.61BDividend Yield3.12%2.92%5.33%4.82%P/E Ratio-1.354.2823.55141.21Price / Sales228.45575.41388.19284,066.48Price / Cash2.2510.2538.1728.14Price / Book1.056.556.894.64Net Income-£1.63M£20.70B£3.20B£5.83B7 Day Performance-6.20%-2.72%-3.06%1.44%1 Month Performance-7.13%-2.95%1.51%7.39%1 Year Performance-27.85%92.65%9.35%112.59% N4 Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)N4PN4 PharmaN/AGBX 0.47-1.3%N/A-27.8%£2.02M£8,841.37-1.355HELDHellenic DynamicsN/AGBX 0.95flatN/AN/A£1.40MN/A-0.27N/AHLNHaleon0.6508 of 5 starsGBX 393.60-0.1%GBX 420+6.7%+17.2%£35.52B£11.07B33.1025,408BXPBeximco PharmaceuticalsN/AGBX 37.67-0.9%N/A-2.4%£25.68B£7.08T4.045,500HIKHikma Pharmaceuticals2.7732 of 5 starsGBX 2,022-2.8%GBX 2,436.67+20.5%+2.5%£5.61B£3.74B19.849,100HCMHUTCHMEDN/AGBX 250+2.0%N/A-11.4%£2.71B£771.01M-63.811,760Gap UpINDVIndivior2.1752 of 5 starsGBX 758.50-0.8%GBX 1,650+117.5%-56.8%£1.18B£1.40B-628.911,000News CoverageGap UpAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAPHAlliance Pharma1.7811 of 5 starsGBX 64flatGBX 6,250+9,665.6%+61.7%£346.53M£183.50M-10.3291,000AGYAllergy TherapeuticsN/AGBX 6.70+1.5%N/A+116.0%£329.31M£72.18M-6.46612Gap UpANCRAnimalcare GroupN/AGBX 219flatN/A+4.1%£150.15M£84.90M4.08220 Remove Ads Related Companies and Tools Related Companies Hellenic Dynamics Alternatives Haleon Alternatives Beximco Pharmaceuticals Alternatives Hikma Pharmaceuticals Alternatives HUTCHMED Alternatives Indivior Alternatives Amryt Pharma Alternatives Alliance Pharma Alternatives Allergy Therapeutics Alternatives Animalcare Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:N4P) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding N4 Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share N4 Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
